Oxford, UK – 10 June 2010. OGT, provider of innovative genetics and biomarker solutions to advance molecular medicine, today announced that its CytoSure® Interpret Software can now seamlessly transfer array comparative genomic hybridisation (aCGH) aberration data directly to Cartagenia’s Bench™ constitutional cytogenetics platform. This helps cytogeneticists accurately correlate genotypic findings with known clinical phenotypes. Further details of this new functionality will be presented in two workshops at the European Human Genetics Conference 2010 in Gothenburg, Sweden, 12-15 June. On 12 June, OGT will present “From disease to cytogenetics research – An integrated CNV analysis platform from Oxford Gene Technology” at 12.00 in room H1. Following on from this at 14.00 in room R4, Cartagenia will present “Routine clinical interpretation of copy number variation".
With the ability to automatically detect CNV aberrations, CytoSure Interpret Software generates reliable and reproducible results, which can be cross referenced with external aberration databases for accurate data interpretation. These results can now be effortlessly transferred to Cartagenia’s Bench platform, allowing additional data management options — including quick and secure data sharing within, and across, various research facilities — and support for genotypephenotype correlation analysis.
OGT and Cartagenia will be exhibiting at ESHG 2010 on booths B-550 and B-632 respectively.
Paper published in npj Genomic Medicine demonstrates identification of more reportable CNVs with CytoSure® v3 vs traditional array design.
ReadRobust panel enables accurate and comprehensive constitutional genetic aberration screening in one assay.
ReadCytoSure™ NGS – Combining the benefits of microarrays and NGS in a single assay.
Read